Press Releases

RARITAN, N.J. (July 6, 2020) – Ortho Clinical Diagnostics, a global leader of in vitro diagnostics backed by The Carlyle Group, announced Joseph M. Busky has joined the Company as Chief Financial Officer, effective July 7, 2020. Busky, who previously served as Chief Financial Officer for Vyaire
Jul 06, 2020
Ortho’s COVID-19 total antibody test receives CE Mark  Ortho’s total antibody test may be used as aid in diagnosis and to support decisions for getting people back to work The test offers excellent performance, with 100 percent specificity and sensitivity Ortho began shipping its antibody test to
May 12, 2020
Ortho announces FDA Emergency Use Authorization received for its second COVID-19 antibody test Similar to Ortho's total COVID-19 antibody test, Ortho's IgG test demonstrated  100% specificity  and can be used to support decisions for getting people back to work  Ortho has already begun shipping its
Apr 25, 2020
Aligned with its mission to improve and save lives with diagnostics, Ortho Clinical Diagnostics today announced it is launching to market its SARS-CoV-2 (COVID-19/coronavirus) antibody test—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack.
Apr 03, 2020
​​​​​ Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, today announced it has been honored with a bronze Edison Award in the category of Medical/Dental Testing Solutions for its VITROS® XT Solutions,
Mar 18, 2020
Recognition is latest for Ortho Care™, Ortho’s award-winning customer service and support program Ortho Clinical Diagnostics, a global leader of in vitro diagnostics dedicated to improving and saving lives through innovative laboratory solutions, has been named a bronze medal winner at the 14th
Mar 03, 2020
Displaying 41 - 50 of 116